Corvus Capital Ltd., Manoira Corporation, and Andrew Regan filed Amendment No. 7 to their Schedule 13D with the SEC on October 27, 2026, disclosing updated beneficial ownership positions in CDT Equity Inc. (NASDAQ:CDT) following a share issuance on October 22, 2026.

Key Highlights

  • Triggering event: On October 22, 2026, CDT Equity Inc. issued 1,347,616 shares of Common Stock to Manoira Corporation at $0.1447 per share, in full satisfaction of a one-time $195,000 fee under an Evaluation Agreement.
  • Andrew Regan total ownership: Regan beneficially owns 2,064,698 shares, representing 22.1% of the class, as of October 26, 2026.
  • Corvus Capital ownership: Corvus Capital Ltd. holds shared voting and dispositive power over 1,565,080 shares, equal to 16.8% of the class.
  • Manoira Corporation ownership: Manoira Corporation holds shared voting and dispositive power over 1,347,619 shares, equal to 14.5% of the class.
  • Share count basis: All percentages are based on 9,322,805 shares of Common Stock outstanding as of October 23, 2026, as provided by the Issuer.
  • Two reverse splits: Share counts give effect to a 1-for-10 reverse stock split on July 20, 2026 and a 1-for-25 reverse stock split on September 28, 2026.

Evaluation Agreement and Share Issuance Drive Amendment No. 7

According to the filing, on October 22, 2026, Manoira Corporation entered into an Evaluation Agreement with CDT Equity Inc., a Delaware corporation formerly known as Conduit Pharmaceuticals Inc. Under the terms of that agreement, Manoira agreed to evaluate certain clinical stage compounds of the Issuer for animal health applications. In return, the Issuer agreed to pay Manoira a one-time fee of $195,000. The filing states that, also on October 22, 2026, the Issuer satisfied that fee in full by issuing 1,347,616 shares of Common Stock to Manoira at a price of $0.1447 per share.

The three reporting persons are Corvus Capital Ltd., a Cayman Islands exempted company; Manoira Corporation, a Delaware corporation; and Dr. Andrew Regan, a British citizen. The filing states that Corvus owns 87.0% of the equity interests of Manoira, and that Dr. Regan is the Chief Executive Officer and sole shareholder of Corvus. The filing also identifies Dr. Regan's principal occupation as acting as Chief Executive Officer of Corvus Capital and as Chief Executive Officer of the Issuer.

As of October 26, 2026, Andrew Regan's aggregate beneficial ownership stood at 2,064,698 shares, comprising 499,618 shares held with sole voting and dispositive power, and 1,565,080 shares held with shared voting and dispositive power. The filing notes that all share figures reflect the Issuer's 1-for-10 reverse stock split effected on July 20, 2026 and its 1-for-25 reverse stock split effected on September 28, 2026. This Amendment No. 7 amends an Original Schedule 13D first filed on September 29, 2023, and supplements six prior amendments.

What Was Disclosed

Amendment No. 7 to the Schedule 13D reports that Manoira received 1,347,616 shares from CDT Equity on October 22, 2026 as payment under an Evaluation Agreement, and discloses updated beneficial ownership percentages of 22.1%, 16.8%, and 14.5% for Andrew Regan, Corvus Capital, and Manoira, respectively.